Atlantic Edge Private Wealth Management, LLC Olema Pharmaceuticals, Inc. Transaction History
Atlantic Edge Private Wealth Management, LLC
- $403 Billion
- Q4 2025
A detailed history of Atlantic Edge Private Wealth Management, LLC transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Atlantic Edge Private Wealth Management, LLC holds 50 shares of OLMA stock, worth $434. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50Holding current value
$434% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding OLMA
# of Institutions
137Shares Held
66.3MCall Options Held
379KPut Options Held
13K-
Bain Capital Life Sciences Investors, LLC Boston, MA6.84MShares$59.5 Million21.2% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY6.79MShares$59 Million2.11% of portfolio
-
Bvf Inc San Francisco, CA5.3MShares$46 Million2.76% of portfolio
-
Black Rock Inc. New York, NY4MShares$34.8 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X03.59MShares$31.2 Million0.02% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $351M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...